TrialLancet (London, England)2019

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.

R Sharon Chinthrajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.